- Home
- NRXP vs HGBL Comparison
NRXP vs HGBL Comparison
Compare NRXP & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- HGBL
- Stock Information
- Founded
- NRXP 2015
- HGBL 1937
- Country
- NRXP United States
- HGBL United States
- Employees
- NRXP N/A
- HGBL N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- HGBL Business Services
- Sector
- NRXP Health Care
- HGBL Consumer Discretionary
- Exchange
- NRXP Nasdaq
- HGBL Nasdaq
- Market Cap
- NRXP 58.5M
- HGBL 66.7M
- IPO Year
- NRXP N/A
- HGBL N/A
- Fundamental
- Price
- NRXP $3.58
- HGBL $1.63
- Analyst Decision
- NRXP Strong Buy
- HGBL Strong Buy
- Analyst Count
- NRXP 5
- HGBL 1
- Target Price
- NRXP $31.40
- HGBL $4.00
- AVG Volume (30 Days)
- NRXP 416.8K
- HGBL 130.1K
- Earning Date
- NRXP 11-13-2025
- HGBL 11-06-2025
- Dividend Yield
- NRXP N/A
- HGBL N/A
- EPS Growth
- NRXP N/A
- HGBL N/A
- EPS
- NRXP N/A
- HGBL 0.10
- Revenue
- NRXP N/A
- HGBL $48,940,000.00
- Revenue This Year
- NRXP N/A
- HGBL $23.07
- Revenue Next Year
- NRXP $395.09
- HGBL $4.49
- P/E Ratio
- NRXP N/A
- HGBL $16.36
- Revenue Growth
- NRXP N/A
- HGBL N/A
- 52 Week Low
- NRXP $1.10
- HGBL $1.56
- 52 Week High
- NRXP $6.01
- HGBL $2.39
- Technical
- Relative Strength Index (RSI)
- NRXP 67.97
- HGBL 25.33
- Support Level
- NRXP $3.19
- HGBL $1.58
- Resistance Level
- NRXP $3.84
- HGBL $1.65
- Average True Range (ATR)
- NRXP 0.22
- HGBL 0.06
- MACD
- NRXP 0.05
- HGBL -0.01
- Stochastic Oscillator
- NRXP 70.87
- HGBL 4.69
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About HGBL Heritage Global Inc.
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.